ipatasertib
Showing 1 - 25 of 40
Solid Tumors Trial in Shanghai City (Ipatasertib)
Active, not recruiting
- Solid Tumors
- Ipatasertib
-
Shanghai City, ChinaFudan University Shanghai Cancer Center
Jan 8, 2023
Triple Negative Breast Cancer Trial in London (Atezolizumab, Ipatasertib, Paclitaxel)
Active, not recruiting
- Triple Negative Breast Cancer
- Atezolizumab
- +4 more
-
London, United KingdomBarts Health NHS Trust
Aug 10, 2022
Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy,
Not yet recruiting
- Locally Advanced Malignant Solid Neoplasm
- +2 more
- Biopsy
- +5 more
- (no location specified)
Nov 8, 2022
Castrate Resistant Prostate Cancer Trial in Chicago, Indianapolis, Hershey (Ipatasertib, Darolutamide, Androgen Deprivation
Recruiting
- Castrate Resistant Prostate Cancer
- Ipatasertib
- +2 more
-
Chicago, Illinois
- +2 more
Jul 19, 2022
Metastatic Breast Cancer Trial in Spain (Ipatasertib, Trastuzumab, Pertuzumab)
Recruiting
- Metastatic Breast Cancer
- Ipatasertib
- +2 more
-
Badalona, Barcelona, Spain
- +9 more
Oct 24, 2022
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Metastatic
Not yet recruiting
- FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
- +4 more
- Computed Tomography
- +3 more
- (no location specified)
Sep 13, 2022
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma
Recruiting
- Fallopian Tube Endometrioid Adenocarcinoma
- +17 more
- Biopsy
- +3 more
-
Augusta, Georgia
- +4 more
Jan 25, 2023
Cancer Trial (Ipatasertib)
Not yet recruiting
- Cancer
- Ipatasertib
- (no location specified)
May 16, 2023
Breast Cancer Trial in Worldwide (Ipatasertib, Placebo, Palbociclib)
Active, not recruiting
- Breast Cancer
- Ipatasertib
- +3 more
-
Atlanta, Georgia
- +19 more
Dec 5, 2022
Breast Cancer Trial in Boston (Ipatasertib, Fulvestrant, Aromatase Inhibitor)
Recruiting
- Breast Cancer
- Ipatasertib
- +3 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Oct 25, 2021
Triple Negative Breast Cancer Trial in Portugal, Spain (Ipatasertib, Capecitabine, Eribulin)
Recruiting
- Triple Negative Breast Cancer
- Ipatasertib
- +4 more
-
Amadora, Lisboa, Portugal
- +16 more
Jun 10, 2022
NSCLC Stage IV, NSCLC Stage IIIB Trial in United States (Ipatasertib)
Recruiting
- NSCLC Stage IV
- NSCLC Stage IIIB
- Ipatasertib
-
Fairway, Kansas
- +4 more
Nov 29, 2021
Breast Cancer Trial in Worldwide (Ipatasertib, Paclitaxel, Atezolizumab)
Completed
- Breast Cancer
- Ipatasertib
- +4 more
-
Long Beach, California
- +17 more
Apr 22, 2022
Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +23 more
- Biospecimen Collection
- +2 more
-
Los Angeles, California
- +1 more
Jul 7, 2022
Breast Cancer Trial in Villejuif (Atezolizumab Injection, Ipatasertib, Bevacizumab)
Recruiting
- Breast Cancer
- Atezolizumab Injection
- +4 more
-
Villejuif, FranceGustave Roussy
Mar 9, 2022
Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced
Recruiting
- Head and Neck Carcinoma of Unknown Primary
- +24 more
- Cisplatin
- +2 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Aug 6, 2022
Early-stage Breast Cancer Trial in Heidelberg (Atezolizumab 1200 mg in 20 ML Injection, Inavolisib, Ipatasertib)
Not yet recruiting
- Early-stage Breast Cancer
- Atezolizumab 1200 mg in 20 ML Injection
- +5 more
-
Heidelberg, Baden-Wuerttemberg, GermanyNational Center for Tumor Diseases
Sep 13, 2022
Metastatic or Locally Advanced Malignancies Trial in Germany (Vemurafenib, Cobimetinib, Atezolizumab)
Recruiting
- Metastatic or Locally Advanced Malignancies
- Vemurafenib
- +7 more
-
Berlin, Germany
- +5 more
Jan 2, 2023
Breast Cancer Trial in Australia, Canada, New Zealand (Ipatasertib, Fulvestrant, Placebo)
Recruiting
- Breast Cancer
- Ipatasertib
- +2 more
-
Bowral, New South Wales, Australia
- +37 more
Aug 8, 2022
Gastric Cancer Trial in Worldwide (5-Fluorouracil, Ipatasertib, Leucovorin)
Ovarian Tumors Trial in New York (Ipatasertib, Paclitaxel)
Withdrawn
- Ovarian Neoplasms
- Ipatasertib
- Paclitaxel
-
New York, New YorkDubin Breast Center
Oct 2, 2020
Endometrial Cancer Trial in United States (Atezolizumab - 28 Day Cycle, Bevacizumab, Ipatasertib)
Recruiting
- Endometrial Cancer
- Atezolizumab - 28 Day Cycle
- +6 more
-
Duarte, California
- +13 more
Jun 8, 2022